Ocular Drug Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510240988

Publication Date:

October 31, 2024

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Ocular drug delivery system designed to treat eye locally, whereas the conventional method of drug delivery is less effective due to the presence of various barriers.
The global market for Ocular Drug Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ocular Drug Delivery System by region & country, by Type, and by Application.
The Ocular Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery System.
Market Segmentation
By Company
Ocular Therapeutix
Alimera Sciences
Allergan
Graybug Vision
Bausch Health
EyePoint Pharmaceuticals
Santen Pharmaceutical
Taiwan Liposome
Envisia Therapeutics
Clearside Biomedical
Segment by Type:
Implantable Ocular Drug Delivery Systems
Particulate Drug Delivery Systems
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ocular Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ocular Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ocular Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Ocular Drug Delivery System Product Introduction
1.2 Global Ocular Drug Delivery System Market Size Forecast
1.2.1 Global Ocular Drug Delivery System Sales Value (2019-2030)
1.2.2 Global Ocular Drug Delivery System Sales Volume (2019-2030)
1.2.3 Global Ocular Drug Delivery System Sales Price (2019-2030)
1.3 Ocular Drug Delivery System Market Trends & Drivers
1.3.1 Ocular Drug Delivery System Industry Trends
1.3.2 Ocular Drug Delivery System Market Drivers & Opportunity
1.3.3 Ocular Drug Delivery System Market Challenges
1.3.4 Ocular Drug Delivery System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ocular Drug Delivery System Players Revenue Ranking (2023)
2.2 Global Ocular Drug Delivery System Revenue by Company (2019-2024)
2.3 Global Ocular Drug Delivery System Players Sales Volume Ranking (2023)
2.4 Global Ocular Drug Delivery System Sales Volume by Company Players (2019-2024)
2.5 Global Ocular Drug Delivery System Average Price by Company (2019-2024)
2.6 Key Manufacturers Ocular Drug Delivery System Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Ocular Drug Delivery System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Ocular Drug Delivery System
2.9 Ocular Drug Delivery System Market Competitive Analysis
2.9.1 Ocular Drug Delivery System Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Ocular Drug Delivery System Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery System as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Implantable Ocular Drug Delivery Systems
3.1.2 Particulate Drug Delivery Systems
3.2 Global Ocular Drug Delivery System Sales Value by Type
3.2.1 Global Ocular Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ocular Drug Delivery System Sales Value, by Type (2019-2030)
3.2.3 Global Ocular Drug Delivery System Sales Value, by Type (%) (2019-2030)
3.3 Global Ocular Drug Delivery System Sales Volume by Type
3.3.1 Global Ocular Drug Delivery System Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Ocular Drug Delivery System Sales Volume, by Type (2019-2030)
3.3.3 Global Ocular Drug Delivery System Sales Volume, by Type (%) (2019-2030)
3.4 Global Ocular Drug Delivery System Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgical Centers
4.2 Global Ocular Drug Delivery System Sales Value by Application
4.2.1 Global Ocular Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ocular Drug Delivery System Sales Value, by Application (2019-2030)
4.2.3 Global Ocular Drug Delivery System Sales Value, by Application (%) (2019-2030)
4.3 Global Ocular Drug Delivery System Sales Volume by Application
4.3.1 Global Ocular Drug Delivery System Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Ocular Drug Delivery System Sales Volume, by Application (2019-2030)
4.3.3 Global Ocular Drug Delivery System Sales Volume, by Application (%) (2019-2030)
4.4 Global Ocular Drug Delivery System Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Ocular Drug Delivery System Sales Value by Region
5.1.1 Global Ocular Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ocular Drug Delivery System Sales Value by Region (2019-2024)
5.1.3 Global Ocular Drug Delivery System Sales Value by Region (2025-2030)
5.1.4 Global Ocular Drug Delivery System Sales Value by Region (%), (2019-2030)
5.2 Global Ocular Drug Delivery System Sales Volume by Region
5.2.1 Global Ocular Drug Delivery System Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Ocular Drug Delivery System Sales Volume by Region (2019-2024)
5.2.3 Global Ocular Drug Delivery System Sales Volume by Region (2025-2030)
5.2.4 Global Ocular Drug Delivery System Sales Volume by Region (%), (2019-2030)
5.3 Global Ocular Drug Delivery System Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Ocular Drug Delivery System Sales Value, 2019-2030
5.4.2 North America Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Ocular Drug Delivery System Sales Value, 2019-2030
5.5.2 Europe Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Ocular Drug Delivery System Sales Value, 2019-2030
5.6.2 Asia Pacific Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Ocular Drug Delivery System Sales Value, 2019-2030
5.7.2 South America Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Ocular Drug Delivery System Sales Value, 2019-2030
5.8.2 Middle East & Africa Ocular Drug Delivery System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ocular Drug Delivery System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ocular Drug Delivery System Sales Value
6.2.1 Key Countries/Regions Ocular Drug Delivery System Sales Value, 2019-2030
6.2.2 Key Countries/Regions Ocular Drug Delivery System Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Ocular Drug Delivery System Sales Value, 2019-2030
6.3.2 United States Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ocular Drug Delivery System Sales Value, 2019-2030
6.4.2 Europe Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ocular Drug Delivery System Sales Value, 2019-2030
6.5.2 China Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ocular Drug Delivery System Sales Value, 2019-2030
6.6.2 Japan Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ocular Drug Delivery System Sales Value, 2019-2030
6.7.2 South Korea Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ocular Drug Delivery System Sales Value, 2019-2030
6.8.2 Southeast Asia Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ocular Drug Delivery System Sales Value, 2019-2030
6.9.2 India Ocular Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ocular Drug Delivery System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ocular Therapeutix
7.1.1 Ocular Therapeutix Company Information
7.1.2 Ocular Therapeutix Introduction and Business Overview
7.1.3 Ocular Therapeutix Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ocular Therapeutix Ocular Drug Delivery System Product Offerings
7.1.5 Ocular Therapeutix Recent Development
7.2 Alimera Sciences
7.2.1 Alimera Sciences Company Information
7.2.2 Alimera Sciences Introduction and Business Overview
7.2.3 Alimera Sciences Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alimera Sciences Ocular Drug Delivery System Product Offerings
7.2.5 Alimera Sciences Recent Development
7.3 Allergan
7.3.1 Allergan Company Information
7.3.2 Allergan Introduction and Business Overview
7.3.3 Allergan Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Allergan Ocular Drug Delivery System Product Offerings
7.3.5 Allergan Recent Development
7.4 Graybug Vision
7.4.1 Graybug Vision Company Information
7.4.2 Graybug Vision Introduction and Business Overview
7.4.3 Graybug Vision Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Graybug Vision Ocular Drug Delivery System Product Offerings
7.4.5 Graybug Vision Recent Development
7.5 Bausch Health
7.5.1 Bausch Health Company Information
7.5.2 Bausch Health Introduction and Business Overview
7.5.3 Bausch Health Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bausch Health Ocular Drug Delivery System Product Offerings
7.5.5 Bausch Health Recent Development
7.6 EyePoint Pharmaceuticals
7.6.1 EyePoint Pharmaceuticals Company Information
7.6.2 EyePoint Pharmaceuticals Introduction and Business Overview
7.6.3 EyePoint Pharmaceuticals Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.6.4 EyePoint Pharmaceuticals Ocular Drug Delivery System Product Offerings
7.6.5 EyePoint Pharmaceuticals Recent Development
7.7 Santen Pharmaceutical
7.7.1 Santen Pharmaceutical Company Information
7.7.2 Santen Pharmaceutical Introduction and Business Overview
7.7.3 Santen Pharmaceutical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Santen Pharmaceutical Ocular Drug Delivery System Product Offerings
7.7.5 Santen Pharmaceutical Recent Development
7.8 Taiwan Liposome
7.8.1 Taiwan Liposome Company Information
7.8.2 Taiwan Liposome Introduction and Business Overview
7.8.3 Taiwan Liposome Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Taiwan Liposome Ocular Drug Delivery System Product Offerings
7.8.5 Taiwan Liposome Recent Development
7.9 Envisia Therapeutics
7.9.1 Envisia Therapeutics Company Information
7.9.2 Envisia Therapeutics Introduction and Business Overview
7.9.3 Envisia Therapeutics Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Envisia Therapeutics Ocular Drug Delivery System Product Offerings
7.9.5 Envisia Therapeutics Recent Development
7.10 Clearside Biomedical
7.10.1 Clearside Biomedical Company Information
7.10.2 Clearside Biomedical Introduction and Business Overview
7.10.3 Clearside Biomedical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Clearside Biomedical Ocular Drug Delivery System Product Offerings
7.10.5 Clearside Biomedical Recent Development
8 Industry Chain Analysis
8.1 Ocular Drug Delivery System Industrial Chain
8.2 Ocular Drug Delivery System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ocular Drug Delivery System Sales Model
8.5.2 Sales Channel
8.5.3 Ocular Drug Delivery System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Ocular Therapeutix
Alimera Sciences
Allergan
Graybug Vision
Bausch Health
EyePoint Pharmaceuticals
Santen Pharmaceutical
Taiwan Liposome
Envisia Therapeutics
Clearside Biomedical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂